|
|
||
A range of engineering materials currently are used for orthopedic devices: cobalt chromium alloys; titanium alloys; ceramics such as alumina and zirconia; polymers such as PEEK and UHMWPE; and elastomers such as silicone, polyurethane, etc.
![]() Implant design and materials choices can restrict the concentration of particles that develop during the life cycle of an implant; however, some wear particles are unavoidable. Photo courtesy of Janet Cotton. |
Wear particles are the debris released between two articulating parts of an orthopedic device.
The presence of wear debris invokes a cascade of cell responses that lead to the formation of osteoclasts (specialized cells responsible for breaking down bone tissue) and loosening of the implant. Further, the presence of debris also inhibits the formation of osteo-blasts (cells responsible for bone formation) and thus adversely affects osteointegration, the connection between living bone and an artificial implant.
Bone is constantly remodeled and is in a repetitive process of resorption and reformation. Both processes are controlled through cell-signaling substances, or cytokines. Osteoclasts, the bone cells responsible for breaking down bone tissue, are activated through the release of cytokines by cells called macrophages, as well as by fibroblast and osteoblast cells. Osteo-blast cells, which build up new bone material through maturation, transition into inactive osteocytes. Similarly, fibroblast cells are those that build up fibrous tissue. Macrophages are cells that phagocytose foreign bodies by engulfing them.
When macrophages encounter foreign bodies in the tissue surrounding implants, such as wear particles, they respond by phagocytosing and engulfing the particles in an attempt to destroy the particles. Since wear debris produced by orthopedic devices cannot be phagocytosed in this way, the process of phagocytosis becomes interrupted. When this happens, cytokines are released. These cytokines disrupt the natural bone-remodeling process, eventually leading to bone resorption. This article describes the influence of various particles on cytokine release. If this can be properly understood, the influence of wear debris on the natural remodeling of bone can thus be understood as well. Consequently, the success or failure of an implant can be predicted to some degree.
Mechanical factors also may contribute to osteolysis. Factors such as load mismatch or stress-shielding and the action of micromotion can lead to the release of cytokines and may result in eventual loosening of the prosthesis. Other mechanical factors also can lead to the development of wear debris through micromotion at the bone-implant interface, which can then result in cytokine release.
During the normal functioning of the device, a concentration of wear debris migrates into the tissue adjacent to the bone, the periprosthetic tissue, and when it does so, macrophages already in the vicinity respond to the foreign particles. At this point, the macrophages release cytokines, which recruit further macrophages to the site. This causes further vascularization through the development of a fibrous membrane around the joint space, allowing blood flow to place macro-phages and cytokines to the area.
When the particle concentration is low, particles can be removed by the body’s lymphatic system through the release of leukocytes. If the particle concentration is too high to be removed by the lymphatic system, the macrophages in the vicinity attempt to engulf the wear particles by phagocytosis.
The purpose of phagocytosis is to remove the particle from the joint space and destroy it. The byproducts of such a process normally would be taken away from the joint space through the lymphatic system. If the foreign body cannot be destroyed, then the process of phagocytosis is disrupted. The disruption of the process causes expression of cytokines, and through a cascade of reactions, ultimately leads to osteolysis. The reactions cause the activation of osteoclast cells, which lead to bone dissolution at the joint site. This is what causes the implant to loosen, which leads to the failure of the implant.2
In the case of polymeric particles such as UHMWPE and PEEK, it is the presence of these particles that cause phagocytosis as they release negligible levels of toxic ions.
The size range of particles released from metallic materials, which is considered to be acceptable in terms of contrast, can have a cytotoxic and genotoxic effect as a result of release of ions.
Metallic materials such as cobalt chromium alloys produce fine debris, which has less of a size effect than UHMWPE particles for example, but the particles release chromium and cobalt ions. In certain valency states, chromium can be genotoxic (causing DNA damage) and cytotoxic (toxic to cells). Soluble metal corrosion products and particulate metallic debris may promote both local and systematic exposure since they are easily circulated around the body. These soluble elements have been found in the liver, spleen and para-aortic lymph nodes.3
To a lesser extent, cobalt chromium alloys and stainless steels also form a passive layer spontaneously, and for this reason, are second to titanium alloys in their potential cyctoxicty and genotoxicity effect. Ceramics are generally biocompatible, and particles have limited cytotoxic effects and foreign body inflammatory response.
Elastomeric particles also have been shown to have toxic effects, Silastic, a silicone polymer used in hand joint replacements and increasingly in spinal intervention products, has been shown to produce wear debris of the order of 10-100 m in particle size when used for finger joint replacements.
The accumulation of these particles has been found to promote a significant foreign body reaction ranging from the presence of macrophages and giant cells and may cause silicone synovitis (inflammation of the synovial membrane). Polyurethane also has been investigated as an acetabular cup material for total hip replacements and shows good wear properties both in vivo4 and in laboratory studies.5
Wear particle analysis is conducted during biomechanical testing of a device. The device is placed in the tester within a reservoir of fluid to simulate the lubrication conditions of the human body when the device is in vivo. This fluid is either saline or bovine serum, and the tests are usually run at 37 degrees Celcius up to 10 million wear cycles. usually after each million wear cycles, a sample of the test fluid is taken for wear particle analysis. The volume of the fluid taken is approximately 10 ml.
If the fluid is bovine serum, the particles must be digested out of the serum by means of an acid treatment or an enzyme treatment. The type of treatment depends on the wear particle material; acid treatments are used for ceramic and UHMWPE wear particles, whereas enzymatic treatments are used for metallic and elastomeric particles.
Once the particles have been isolated by means of an enzyme or acid treatment, the remaining fluid with the suspended wear particles is sequentially filtered through four microscopic filters. First, it is filtered through a 10 µm filter, then a 1 µm, then a 0.1 µm filter and finally a 0.015 µm filter.
These filters are imaged in scanning electron microscopes; the fine filters imaged with field emission gun SEMs in order to resolve very fine particles on the nanometer size range. The images captured from each filter are processed so that the graphical information is captured electronically. This is processed in order to generate particle parameter histograms.
The levels of wear debris must be reduced for implants to show longer life cycles in vivo. Wear debris generation is a concern for large joint replacement, finger joint replacement and, more recently, spine arthroplasty devices. The traditional metal-on-poly combinations have been replaced by metal-on-metal combinations in an attempt to reduce wear particle concentrations that ultimately develop over time. In spite of this, the concern about metallic wear debris and possible long-term systemic effects of ion release from the particles cannot be ignored. Consequently, other materials are being considered, such as ceramics and various coatings on metallic substrates for joint replacement.
References
1. Kondrashov, D.G., Hannibal, M., Hsu, K., Zucherman, J., Orthopaedic Surgery, “US Musculoskeletal Review 2006,” 58-60; www.touchbriefings. com/pdf/1857/kondrashov.pdf.
2. Athanasou N.A. “The Pathology of Joint Replacement. Current Diagnostic Pathology.” (2002) 8, 26-32.
3. Wang J.Y., Wickland B.H., Gustilo R.B., Tsukayama D.T. “Titanium, Chromium and Cobalt Ions Modulate the Release of Bone-Associated Cytokines by Human Monocytes/ Macro-phages In Vitro.” Biomaterials. (1996) 17, 2,233-2,240.
4. Imran Khan, Nigel Smith, Eric Jones, Dudley S. Finch, Ruth Elizabeth Cameron; “Analysis and Evaluation of a Biomedical Polycarbonate Urethane Tested in an in vitro Study and an Ovine Arthroplasty Model; Biomaterials” 26 (2005), 633–643.
5. Christian J. Schwartz, Shyam Bahadur; “Development and Testing of a Novel Joint Wear Simulator and Investigation of the Viability of an Elastomeric Polyurethane for Total-Joint Arthroplasty Devices,” Wear, 262 (2007), 331–339.